Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Marijuana Abuse | 10 | 2021 | 251 | 2.800 |
Why?
|
| Impulsive Behavior | 8 | 2016 | 85 | 2.190 |
Why?
|
| Cannabis | 8 | 2023 | 115 | 2.070 |
Why?
|
| Smoking Cessation | 15 | 2023 | 1034 | 2.060 |
Why?
|
| Substance-Related Disorders | 12 | 2021 | 1242 | 1.800 |
Why?
|
| Acetylcysteine | 9 | 2021 | 296 | 1.690 |
Why?
|
| Marijuana Smoking | 6 | 2020 | 108 | 1.520 |
Why?
|
| Cigarette Smoking | 6 | 2020 | 104 | 1.330 |
Why?
|
| Smokers | 8 | 2022 | 200 | 1.300 |
Why?
|
| Borderline Personality Disorder | 4 | 2015 | 13 | 1.200 |
Why?
|
| Social Environment | 2 | 2020 | 182 | 1.140 |
Why?
|
| Smoking | 6 | 2021 | 1452 | 1.070 |
Why?
|
| Behavior, Addictive | 2 | 2020 | 317 | 1.030 |
Why?
|
| Tobacco Products | 5 | 2021 | 234 | 1.010 |
Why?
|
| Craving | 5 | 2022 | 200 | 1.000 |
Why?
|
| Young Adult | 28 | 2023 | 5717 | 0.990 |
Why?
|
| Alcohol Drinking | 5 | 2020 | 805 | 0.990 |
Why?
|
| Stress, Psychological | 4 | 2020 | 824 | 0.940 |
Why?
|
| Free Radical Scavengers | 4 | 2019 | 112 | 0.920 |
Why?
|
| Depression | 3 | 2019 | 943 | 0.890 |
Why?
|
| Hallucinogens | 1 | 2022 | 14 | 0.830 |
Why?
|
| Medication Adherence | 6 | 2020 | 335 | 0.810 |
Why?
|
| Tobacco Use Disorder | 7 | 2023 | 432 | 0.780 |
Why?
|
| Adolescent | 30 | 2023 | 8912 | 0.750 |
Why?
|
| Cues | 4 | 2022 | 654 | 0.720 |
Why?
|
| Adult | 33 | 2023 | 21403 | 0.690 |
Why?
|
| Smoking Devices | 1 | 2019 | 6 | 0.680 |
Why?
|
| False Negative Reactions | 1 | 2019 | 63 | 0.650 |
Why?
|
| Female | 40 | 2022 | 38074 | 0.640 |
Why?
|
| Male | 38 | 2022 | 37321 | 0.640 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 931 | 0.630 |
Why?
|
| Humans | 55 | 2023 | 68618 | 0.630 |
Why?
|
| Health Services Research | 1 | 2019 | 209 | 0.590 |
Why?
|
| Monitoring, Ambulatory | 1 | 2018 | 84 | 0.590 |
Why?
|
| Cannabinoids | 1 | 2017 | 90 | 0.560 |
Why?
|
| Tobacco Use | 5 | 2022 | 98 | 0.550 |
Why?
|
| Data Collection | 1 | 2018 | 420 | 0.540 |
Why?
|
| Sensation | 1 | 2016 | 49 | 0.540 |
Why?
|
| Affect | 2 | 2015 | 218 | 0.540 |
Why?
|
| Varenicline | 3 | 2021 | 98 | 0.530 |
Why?
|
| Research Design | 2 | 2021 | 729 | 0.510 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2016 | 782 | 0.510 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2019 | 468 | 0.500 |
Why?
|
| Precision Medicine | 1 | 2016 | 111 | 0.500 |
Why?
|
| Double-Blind Method | 6 | 2021 | 1738 | 0.480 |
Why?
|
| Self Report | 5 | 2021 | 371 | 0.480 |
Why?
|
| Marijuana Use | 3 | 2018 | 35 | 0.450 |
Why?
|
| Depressive Disorder | 1 | 2015 | 621 | 0.390 |
Why?
|
| Progesterone | 2 | 2022 | 115 | 0.370 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 2077 | 0.360 |
Why?
|
| Behavior Therapy | 3 | 2022 | 297 | 0.320 |
Why?
|
| Middle Aged | 17 | 2022 | 21147 | 0.310 |
Why?
|
| Tobacco Smoking | 2 | 2020 | 41 | 0.310 |
Why?
|
| Dronabinol | 2 | 2019 | 84 | 0.310 |
Why?
|
| Personality Disorders | 3 | 2014 | 44 | 0.300 |
Why?
|
| Ecological Momentary Assessment | 2 | 2018 | 16 | 0.300 |
Why?
|
| Alcoholism | 3 | 2022 | 1109 | 0.290 |
Why?
|
| Comorbidity | 5 | 2019 | 1426 | 0.280 |
Why?
|
| Motivation | 3 | 2019 | 561 | 0.270 |
Why?
|
| Smoking Prevention | 2 | 2018 | 259 | 0.260 |
Why?
|
| Minority Groups | 2 | 2020 | 197 | 0.250 |
Why?
|
| Factor Analysis, Statistical | 2 | 2016 | 201 | 0.240 |
Why?
|
| Tobacco | 2 | 2023 | 161 | 0.230 |
Why?
|
| Breath Tests | 2 | 2021 | 23 | 0.230 |
Why?
|
| Carbon Monoxide | 2 | 2021 | 58 | 0.220 |
Why?
|
| Pilot Projects | 3 | 2022 | 1342 | 0.220 |
Why?
|
| Smartphone | 2 | 2021 | 69 | 0.220 |
Why?
|
| Saliva | 2 | 2022 | 142 | 0.220 |
Why?
|
| Telemedicine | 2 | 2022 | 700 | 0.220 |
Why?
|
| Tobacco Use Cessation | 1 | 2023 | 44 | 0.210 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2022 | 20 | 0.210 |
Why?
|
| Estradiol | 2 | 2021 | 176 | 0.210 |
Why?
|
| Biomarkers | 2 | 2018 | 1593 | 0.200 |
Why?
|
| Domestic Violence | 1 | 2022 | 36 | 0.200 |
Why?
|
| Parents | 2 | 2022 | 312 | 0.200 |
Why?
|
| Prevalence | 6 | 2020 | 1619 | 0.200 |
Why?
|
| Environment | 1 | 2022 | 115 | 0.200 |
Why?
|
| Oxytocin | 2 | 2020 | 124 | 0.190 |
Why?
|
| Puberty | 1 | 2021 | 10 | 0.190 |
Why?
|
| Sexual Maturation | 1 | 2021 | 10 | 0.190 |
Why?
|
| Adolescent Development | 1 | 2021 | 28 | 0.190 |
Why?
|
| Feasibility Studies | 2 | 2022 | 652 | 0.190 |
Why?
|
| Sex Factors | 3 | 2020 | 1266 | 0.190 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 52 | 0.180 |
Why?
|
| Surveys and Questionnaires | 4 | 2018 | 2800 | 0.180 |
Why?
|
| Child Development | 1 | 2021 | 102 | 0.180 |
Why?
|
| Vaping | 1 | 2022 | 124 | 0.170 |
Why?
|
| Patient Compliance | 2 | 2019 | 402 | 0.170 |
Why?
|
| Models, Psychological | 3 | 2016 | 180 | 0.170 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2022 | 180 | 0.170 |
Why?
|
| Stress, Physiological | 1 | 2020 | 215 | 0.160 |
Why?
|
| Treatment Outcome | 6 | 2019 | 7029 | 0.160 |
Why?
|
| Legislation, Drug | 1 | 2018 | 9 | 0.160 |
Why?
|
| Personal Satisfaction | 1 | 2019 | 123 | 0.160 |
Why?
|
| Disasters | 1 | 2020 | 204 | 0.160 |
Why?
|
| Students | 1 | 2020 | 233 | 0.150 |
Why?
|
| Adolescent Behavior | 1 | 2020 | 264 | 0.150 |
Why?
|
| Child | 5 | 2022 | 6405 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2019 | 295 | 0.150 |
Why?
|
| Counseling | 1 | 2019 | 280 | 0.150 |
Why?
|
| Public Service Announcements as Topic | 1 | 2017 | 2 | 0.150 |
Why?
|
| Video Recording | 1 | 2018 | 145 | 0.140 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 848 | 0.140 |
Why?
|
| United States | 6 | 2022 | 7367 | 0.140 |
Why?
|
| Public Health | 1 | 2018 | 201 | 0.140 |
Why?
|
| Underage Drinking | 1 | 2016 | 25 | 0.140 |
Why?
|
| Socioeconomic Factors | 2 | 2021 | 955 | 0.130 |
Why?
|
| Mobile Applications | 1 | 2018 | 138 | 0.130 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2019 | 435 | 0.130 |
Why?
|
| Sleep | 1 | 2017 | 263 | 0.130 |
Why?
|
| Antioxidants | 1 | 2017 | 304 | 0.120 |
Why?
|
| Patient Selection | 1 | 2019 | 592 | 0.120 |
Why?
|
| Incidence | 1 | 2019 | 1603 | 0.120 |
Why?
|
| Reward | 1 | 2016 | 201 | 0.120 |
Why?
|
| Anxiety | 1 | 2017 | 422 | 0.120 |
Why?
|
| Fear | 1 | 2015 | 239 | 0.120 |
Why?
|
| Sex Distribution | 1 | 2014 | 274 | 0.120 |
Why?
|
| Age Distribution | 1 | 2014 | 320 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 1465 | 0.110 |
Why?
|
| Alcoholic Intoxication | 1 | 2014 | 61 | 0.110 |
Why?
|
| Mood Disorders | 1 | 2014 | 132 | 0.110 |
Why?
|
| Gene-Environment Interaction | 1 | 2013 | 31 | 0.110 |
Why?
|
| Cognition | 2 | 2022 | 513 | 0.110 |
Why?
|
| Anxiety Disorders | 1 | 2014 | 426 | 0.100 |
Why?
|
| Parent-Child Relations | 2 | 2022 | 98 | 0.090 |
Why?
|
| Retrospective Studies | 2 | 2020 | 7277 | 0.090 |
Why?
|
| Sexual Behavior | 1 | 2011 | 183 | 0.090 |
Why?
|
| Administration, Intranasal | 2 | 2020 | 88 | 0.090 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2020 | 1506 | 0.090 |
Why?
|
| Risk Factors | 3 | 2014 | 5731 | 0.080 |
Why?
|
| Quality of Life | 1 | 2017 | 1515 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2010 | 285 | 0.080 |
Why?
|
| Mental Health | 1 | 2010 | 278 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 2279 | 0.070 |
Why?
|
| Recurrence | 2 | 2019 | 948 | 0.070 |
Why?
|
| Age Factors | 2 | 2019 | 1864 | 0.060 |
Why?
|
| Emotions | 2 | 2017 | 244 | 0.060 |
Why?
|
| Luteal Phase | 1 | 2022 | 25 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2020 | 3705 | 0.050 |
Why?
|
| Menstrual Cycle | 1 | 2022 | 64 | 0.050 |
Why?
|
| Sexism | 1 | 2022 | 11 | 0.050 |
Why?
|
| Peer Review | 1 | 2022 | 16 | 0.050 |
Why?
|
| Dehydroepiandrosterone | 1 | 2021 | 29 | 0.050 |
Why?
|
| Cotinine | 1 | 2021 | 40 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 1054 | 0.050 |
Why?
|
| Testosterone | 1 | 2021 | 96 | 0.050 |
Why?
|
| Missouri | 1 | 2020 | 44 | 0.050 |
Why?
|
| Neuroendocrine Cells | 1 | 2020 | 8 | 0.050 |
Why?
|
| Neurosecretory Systems | 1 | 2020 | 21 | 0.050 |
Why?
|
| Alabama | 1 | 2020 | 98 | 0.040 |
Why?
|
| ROC Curve | 1 | 2021 | 392 | 0.040 |
Why?
|
| School Health Services | 1 | 2020 | 72 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2020 | 150 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2020 | 138 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2021 | 329 | 0.040 |
Why?
|
| Schools | 1 | 2020 | 156 | 0.040 |
Why?
|
| Mindfulness | 1 | 2019 | 41 | 0.040 |
Why?
|
| Drug Substitution | 1 | 2018 | 19 | 0.040 |
Why?
|
| Family Therapy | 1 | 2019 | 82 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2020 | 291 | 0.040 |
Why?
|
| Medical Marijuana | 1 | 2018 | 21 | 0.040 |
Why?
|
| Research | 1 | 2019 | 214 | 0.040 |
Why?
|
| Aged | 4 | 2018 | 14862 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2020 | 502 | 0.040 |
Why?
|
| Health Behavior | 1 | 2022 | 458 | 0.040 |
Why?
|
| Time Factors | 2 | 2018 | 4655 | 0.040 |
Why?
|
| Southeastern United States | 1 | 2018 | 281 | 0.040 |
Why?
|
| Communication | 1 | 2020 | 329 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2019 | 183 | 0.040 |
Why?
|
| Sulpiride | 1 | 2017 | 20 | 0.040 |
Why?
|
| Linear Models | 1 | 2019 | 521 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1553 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 951 | 0.030 |
Why?
|
| Intention | 1 | 2017 | 80 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 767 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2014 | 96 | 0.030 |
Why?
|
| South Carolina | 1 | 2020 | 2752 | 0.030 |
Why?
|
| Medical Records | 1 | 2014 | 121 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 3259 | 0.030 |
Why?
|
| Aggression | 1 | 2013 | 98 | 0.030 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2011 | 20 | 0.020 |
Why?
|
| Brain | 1 | 2022 | 2176 | 0.020 |
Why?
|
| Suicidal Ideation | 1 | 2013 | 106 | 0.020 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2011 | 151 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2011 | 257 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 238 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 947 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 786 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2010 | 392 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2010 | 209 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 1851 | 0.020 |
Why?
|
| Algorithms | 1 | 2010 | 1196 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 4848 | 0.010 |
Why?
|